Anbio Biotechnology(NNNN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NNNN Anbio Biotechnology

Pre-Mkt 09-25 06:18:03 EDT

6.15

+0.09

+1.49%

盘前6.54

+0.39+6.39%

05:36 EDT

High6.76	Low6.04	Vol114.58K
Open6.09	D1 Closing6.06	Amplitude11.96%
Mkt Cap884.93M	Tradable Cap244.10M	Total Shares143.89M
T/O733.79K	T/O Rate0.29%	Tradable Shares39.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NNNN","market":"US","secType":"STK","nameCN":"Anbio Biotechnology","latestPrice":6.15,"timestamp":1790280000000,"preClose":6.06,"halted":0,"volume":114578,"hourTrading":{"tag":"盘前","latestPrice":6.5432,"preClose":6.15,"latestTime":"05:36 EDT","volume":83,"amount":533.5145795,"timestamp":1790328999581,"change":0.3932,"changeRate":0.063935,"amplitude":0.065138},"delay":0,"changeRate":0.014851485148514976,"floatShares":39691200,"shares":143891200,"eps":0.146626,"marketStatus":"Pre-Mkt","change":0.09,"latestTime":"09-25 06:18:03 EDT","open":6.09,"high":6.76,"low":6.035,"amount":733792.2978808001,"amplitude":0.119637,"askPrice":7.16,"askSize":100,"bidPrice":6.15,"bidSize":10,"shortable":3,"etf":0,"ttmEps":0.146626,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790343000000},"marketStatusCode":1,"adr":0,"listingDate":1739941200000,"exchange":"NASDAQ","adjPreClose":6.15,"preHourTrading":{"tag":"盘前","latestPrice":6.5432,"preClose":6.15,"latestTime":"05:36 EDT","volume":83,"amount":533.5145795,"timestamp":1790328999581,"change":0.3932,"changeRate":0.063935,"amplitude":0.065138},"postHourTrading":{"tag":"盘后","latestPrice":6.15,"preClose":6.15,"latestTime":"19:40 EDT","volume":345,"amount":2124.53,"timestamp":1790293224070,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3355013341231429},"requestUrl":"/m/hq/s/NNNN/tweets","defaultTab":"tweets","newsList":[{"id":"2660438012","title":"Anbio Biotechnology trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438012","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438012?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:40","pubTimestamp":1786974009,"startTime":"0","endTime":"0","summary":"09:39 EDT Anbio Biotechnology (NNNN) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSEE","JULD","QQQP","BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660943872","title":"NASDAQ Trade Halt Volatility Trading Pause at 09:39 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2660943872","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660943872?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:39","pubTimestamp":1786973988,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 09:39 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nAQN2MF4VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655807443","title":"Anbio Biotechnology trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2655807443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655807443?lang=en_us&edition=fundamental","pubTime":"2026-07-31 01:45","pubTimestamp":1785433531,"startTime":"0","endTime":"0","summary":"13:41 EDT Anbio Biotechnology (NNNN) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNNN","RSEE","QQQP","BK4139","JULD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655807567","title":"NASDAQ Trade Halt Volatility Trading Pause at 01:41 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2655807567","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655807567?lang=en_us&edition=fundamental","pubTime":"2026-07-31 01:41","pubTimestamp":1785433287,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 01:41 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nAQN2MCGFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650113734","title":"U.S. Small Caps Finish Mixed as Polibeli Group Leads, Anbio Biotechnology Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2650113734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650113734?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:21","pubTimestamp":1783714860,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Friday, as the Russell 2000 Index fell 0.5%, while the S&P Small Cap 600 Index was unchanged.Among companies with a market value of $1 billion to $6.7 billion, Anbio Biotechnology was the biggest laggard during the session, dropping 16%, followed by shares of Inhibrx Biosciences Inc., which dropped 10%. Shares of Opendoor Technologies Inc. dropped 10%, Frontier Group Holdings Inc. shares plunged 9.9%, and Hotel101 Global Holdings Corp. tumbled 9.8%.Polibeli Group Ltd. was the best performer, surging 26%, followed by Rackspace Technology Inc., which surged 22%. EquipmentShare.com Inc. Cl A shares jumped 17%, Almonty Industries Inc. surged 13%, and shares of WD-40 Co. jumped 11%.Major U.S. stock indexes climbed Friday as the Nasdaq Composite Index gained 0.3%. Meanwhile, the S&P 500 Index increased 0.4%, and the Dow Jones Industrial Average increased 0.3%.Data source: Dow Jones Ma","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650977317","title":"Anbio Biotechnology Files Mixed Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2650977317","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650977317?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:52","pubTimestamp":1783633944,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology  filed a shelf registration statement on Thursday for the potential sale of securities from time to time.The filing includes Class A ordinary shares, share purchase contracts, share purchase units, warrants, debt securities, rights and units.Net proceeds will be used to fund research, clinical development and product commercialization, as well as for general corporate purposes.Anbio shares fell 5.9% in after-hours trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650972950","title":"Anbio Biotechnology files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972950?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:35","pubTimestamp":1783629312,"startTime":"0","endTime":"0","summary":"16:34 EDT Anbio Biotechnology (NNNN) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642299640","title":"Anbio Biotechnology director David Hsu files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642299640","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642299640?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:46","pubTimestamp":1781275583,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology director David H. Hsu filed an initial Form 3 on March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL3yYRDt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642334914","title":"Anbio Biotechnology falls -22.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642334914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642334914?lang=en_us&edition=fundamental","pubTime":"2026-06-09 00:06","pubTimestamp":1780934768,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology (NNNN) is down -22.7%, or -$5.21 to $17.78. Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-falls-22-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anbio-biotechnology-falls-22-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637037224","title":"Assessing Anbio Biotechnology (NNNN) Valuation After Strong Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2637037224","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637037224?lang=en_us&edition=fundamental","pubTime":"2026-05-24 12:25","pubTimestamp":1779596727,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology stock reacts to recent trading performance\nAnbio Biotechnology (NNNN) has drawn attention after recent trading, with the stock showing a 7.5% move over the past day, 20.7% over the past week, and 32.1% over the past 3 months.\nSee our latest analysis for Anbio Biotechnology.\nWith the share price at $32.52, Anbio Biotechnology has paired strong recent share price momentum over the past week and quarter with a very large 1 year total shareholder return of about 4x. This may...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nnnn/anbio-biotechnology/news/assessing-anbio-biotechnology-nnnn-valuation-after-strong-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nnnn/anbio-biotechnology/news/assessing-anbio-biotechnology-nnnn-valuation-after-strong-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636830298","title":"Anbio Biotechnology Shareholders Approve Sweeping Capital and Governance Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2636830298","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636830298?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:33","pubTimestamp":1779186805,"startTime":"0","endTime":"0","summary":"The latest update is out from Anbio Biotechnology Class A ( ($NNNN) ). On May 15, 2026, Anbio Biotechnology’s Class A shareholders and the wider sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-shareholders-approve-sweeping-capital-and-governance-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-shareholders-approve-sweeping-capital-and-governance-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636837350","title":"Anbio Biotechnology shareholders approve restated charter at extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837350","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636837350?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:06","pubTimestamp":1779185170,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology held shareholder meetings on May 15, 2026, with all resolutions put to shareholders carried.Share capital reduction cleared, cutting the par value of each authorized share to USD 0.000000001 from USD 0.0001; the filing and effectiveness of the reduction were not confirmed.An authorized share capital increase was approved, lifting authorized share capital to USD 3,000 and creating new classes of shares, including Class C ordinary shares and preference shares; implementation was not confirmed.Terms for Class B ordinary shares were endorsed, including an increase in voting rights to 500 votes per share from 50, plus conversion rights into Class A ordinary share; effectiveness was not confirmed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, invest","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL4lrhFX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630346441","title":"Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance Overhaul","url":"https://stock-news.laohu8.com/highlight/detail?id=2630346441","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630346441?lang=en_us&edition=fundamental","pubTime":"2026-04-28 07:02","pubTimestamp":1777330978,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology Class A ( ($NNNN) ) has issued an announcement. Anbio Biotechnology has convened a meeting of Class A shareholders and an extra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-calls-may-15-shareholder-votes-on-sweeping-capital-and-governance-overhaul?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anbio-biotechnology-calls-may-15-shareholder-votes-on-sweeping-capital-and-governance-overhaul?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626131438","title":"Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2626131438","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626131438?lang=en_us&edition=fundamental","pubTime":"2026-04-10 00:46","pubTimestamp":1775753160,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology reported strong 2025 results with sales of $8.65M. The company is diversifying away from COVID products.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/09/Close-up-View-To-Micromanipulation-With-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/09/Close-up-View-To-Micromanipulation-With-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/earnings/26/04/51737825/anbio-biotechnology-posts-solid-fy25-results-diversifies-portfolio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/04/51737825/anbio-biotechnology-posts-solid-fy25-results-diversifies-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["POCT","BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626975518","title":"Anbio Biotechnology CFO Suki Song files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626975518","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626975518?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:02","pubTimestamp":1775692956,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology filed Form 3 naming Suki Song as CFO in an initial beneficial ownership report dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL3Nhv6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626975512","title":"Anbio Biotechnology director Nancy Hartzler files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626975512","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626975512?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:02","pubTimestamp":1775692932,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology director Nancy Hartzler filed an initial statement of beneficial ownership dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL8XBv6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626197551","title":"Anbio Biotechnology CEO Michael Lau files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626197551","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626197551?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:01","pubTimestamp":1775692868,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology filed an initial beneficial ownership statement naming Michael Lau as CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL1h5Y4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626753749","title":"Anbio Biotechnology CBO Chris Tian files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626753749","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626753749?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:00","pubTimestamp":1775692839,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology disclosed a Form 3 filing naming Chris Tian as chief business officer, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2Th2Jg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626753789","title":"Anbio Biotechnology director Cany Xu files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626753789","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626753789?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:00","pubTimestamp":1775692816,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology filed an initial Form 3 listing Cany Xu as a director, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL5V1VLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625965741","title":"Anbio Biotechnology FY25 net income more than doubled to $6.4 million; revenue rises 5.64% to $8.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2625965741","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625965741?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:17","pubTimestamp":1775593066,"startTime":"0","endTime":"0","summary":"Anbio Biotechnology posted fiscal 2025 net income of $6.4 million, up 169.9%.Operating income climbed to $5.8 million from $2 million.Gross margin widened 15.3 percentage points to 87.2%.Results reflected continued orders from key customers, with higher sales of conventional IVD, animal-related, and customized products as demand for COVID-19-related products normalized.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anbio Biotechnology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLbhvJd6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNNN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anbio.com","stockEarnings":[{"period":"1week","weight":0.0982},{"period":"1month","weight":-0.2146},{"period":"3month","weight":-0.5767},{"period":"6month","weight":-0.7429},{"period":"1year","weight":-0.8288},{"period":"ytd","weight":-0.7955}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. IVD products are designed to detect a wide range of biomarkers associated with critical medical domains. Its research and development activities for all IVD products: Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer. Its product AF-1200 Fluorescence Immunoassay Analyzer, AF-100 Fluorescence Immunoassay Analyzer, AF-100S Fluorescence Immunoassay Analyzer, AF-100C Fluorescence Immunoassay Analyzer.","exchange":"NASDAQ","name":"Anbio Biotechnology","nameEN":"Anbio Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anbio Biotechnology(NNNN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Anbio Biotechnology(NNNN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Anbio Biotechnology,NNNN,Anbio Biotechnology股票,Anbio Biotechnology股票老虎,Anbio Biotechnology股票老虎国际,Anbio Biotechnology行情,Anbio Biotechnology股票行情,Anbio Biotechnology股价,Anbio Biotechnology股市,Anbio Biotechnology股票价格,Anbio Biotechnology股票交易,Anbio Biotechnology股票购买,Anbio Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anbio Biotechnology(NNNN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Anbio Biotechnology(NNNN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}